Skip to main content
. 2022 Feb;33(2):401–419. doi: 10.1681/ASN.2021050643

Table 7c.

Time to steroid dependence: During the follow-up period

Group No. of Patients No. of Patients with Frequent Relapses No. of Patients with Steroid Resistance as Competing Event No. of Patients Censored Median (95% CI) (days) Hazard Ratio (95% CI)
MMF 33 16 1 16 461.0 (224.0 to not reached) 2.441 (0.77 to 7.79)
Placebo 18 4 0 14 not reached (64.0 to not reached)